about
Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype.Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.Ultrasound-guided cable-free 13-gauge vacuum-assisted biopsy of non-mass breast lesionsAlu and LINE-1 hypomethylation is associated with HER2 enriched subtype of breast cancer.Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.Potential prognostic value of heat-shock protein 90 in the presence of phosphatidylinositol-3-kinase overexpression or loss of PTEN, in invasive breast cancers.Mammary Carcinoma Arising in Microglandular Adenosis: A Report of Five Cases.Intratumoral heterogeneity of breast cancer xenograft models: texture analysis of diffusion-weighted MR imaging.Feasibility of sentinel lymph node biopsy in breast cancer patients with initial axillary lymph node metastasis after primary systemic therapy.Prognostic value of tumor-associated macrophages according to histologic locations and hormone receptor status in breast cancerIn situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer.A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot MethodThe Expression of Carbonic Anhydrase (CA) IX/XII and Lymph Node Metastasis in Early Breast Cancer.F-18 Sodium Fluoride Positron Emission Tomography/Computed Tomography for Detection of Thyroid Cancer Bone Metastasis Compared with Bone ScintigraphyThe unusual ultrasound features of a breast cholesterol granuloma manifesting as an intracystic mass: case report and literature reviewInterobserver Variability of Ki-67 Measurement in Breast Cancer.Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules.Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H-Ras-induced epithelial to mesenchymal transition.Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancerAssociation between basal-like phenotype and BRCA1/2 germline mutations in Korean breast cancer patients.MicroRNA-222 Expression as a Predictive Marker for Tumor Progression in Hormone Receptor-Positive Breast CancerA Prognostic Model for Patients with Triple-Negative Breast Cancer: Importance of the Modified Nottingham Prognostic Index and Age.Role of second-look ultrasound examinations for MR-detected lesions in patients with breast cancer.Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin.Comparison of sonography with sonographically guided fine-needle aspiration biopsy and core-needle biopsy for initial axillary staging of breast cancer.Comparison of Consecutive Results from Fine Needle Aspiration and Core Needle Biopsy in Thyroid Nodules.The Management Strategy of Benign Solitary Intraductal Papilloma on Breast Core Biopsy.Failure patterns according to molecular subtype in patients with invasive breast cancer following postoperative adjuvant radiotherapy: long-term outcomes in contemporary clinical practice.Reappraisal of conventional risk stratification for local recurrence based on clinical outcomes in 285 resected phyllodes tumors of the breast.Prognostic significance of centromere 17 copy number gain in breast cancer depends on breast cancer subtype.Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer.Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.Diversity index as a novel prognostic factor in breast cancer.A Novel Prognostic Nomogram for Predicting Risks of Distant Failure in Patients with Invasive Breast Cancer Following Postoperative Adjuvant Radiotherapy.Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition.Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.Utility of a formatted pathologic reporting system in thyroid core needle biopsy: A validation study of 1998 consecutive cases.
P50
Q33604942-D23BAA15-785A-4C2D-A690-A279D8448B6AQ33638070-BF129DD6-D7AB-4953-96FC-2357C4B63086Q33811795-DBE5FB28-260A-47FD-A936-EDA34A146FC7Q33817330-90B4EBDE-8AA5-4C0C-8538-4D6A175943F5Q33829480-143F0929-41D5-4623-89CE-E9971AFE9CA3Q33889501-30F75377-9F62-4187-88A9-925DF115942CQ33925576-9E436EAC-71F0-4F9A-BCD7-4FE4847CDBD9Q34219611-5BAEC9E4-FA72-4665-975D-9BABAE9C91CFQ35142216-02B72840-F4AA-4D99-9855-73FBF5A6490BQ35463975-3534ACC1-77EE-4236-B391-B7AF78E4AFEAQ36109108-644402EC-2A7F-4F3D-9716-3F831004BB56Q36277052-35A0D4C6-3B2F-4C52-B2FD-D8848FE0D247Q36482492-948371B0-99A6-44B1-9BE4-B72834E6F81CQ36660730-69E44711-2360-46CC-A022-46DF118F3572Q36662534-B05CC5C3-926B-4DF2-A59D-C38A930D1C84Q36719073-C36232E7-9371-4AD8-B82D-2A65497AD1F8Q37221063-10B4F233-8E48-4AA5-AEA0-3646E106884FQ37275781-2499F873-BBD5-4180-A1AE-B182D654ACB6Q37323046-FA5885B2-2854-4AFB-8201-8E2A76ACE806Q37367870-20AD50FA-A4E7-4603-A350-0F43CA597E92Q37735957-96C518F8-C3C1-43AE-8231-63818DD939B6Q37735965-5DB4D7E0-687F-4B3F-9E21-760103AA90B8Q38427992-FEA77F84-1A9D-4430-B9C1-57B75E6F111EQ38441838-2E4B9261-EC1A-488C-B4E5-551160260B4CQ38444205-9B4E5ED3-58BA-4752-AF1D-7222BF44E988Q38651207-2F2B435D-30AB-4E9C-8F81-7C8EDD2401D4Q38822139-D2C305A8-6FEE-4572-9E4A-F54C7691CF2CQ38896813-F083452B-335F-454D-AB60-8CEC70AE2C76Q39043137-FA644103-724B-40CD-BBE0-5BAF7FDDCE4EQ40419206-1478B62F-46DB-4A39-B766-3DC882BB986BQ41590474-8337A69A-CE7B-4AD0-ACFA-629122AC48C4Q42444701-A8DC14BA-B28D-4471-8124-82065A6F0CB9Q42445173-5ED1154B-A40C-474F-BB0F-C7BD727E069EQ42496731-0C3E7427-7679-4594-A2F9-0D6B4E571AC6Q46121958-BB93E1A0-3E98-4F66-8612-F5F5A56F0A62Q47162348-EFEB9285-699E-46B5-BBA8-AF6F5F23D1BAQ47927841-A826491F-7A3C-4C23-A307-4B3DD3C9ABE2Q47984396-E277F8CB-FC26-46E7-AD07-211528741B08Q48182026-2325E75B-146C-4236-9747-CA9378D7389AQ48272164-8FEF1A5E-F4EF-4DFF-BAE2-DC748B3D1EF5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
So Yeon Park
@ast
So Yeon Park
@en
So Yeon Park
@es
So Yeon Park
@sl
type
label
So Yeon Park
@ast
So Yeon Park
@en
So Yeon Park
@es
So Yeon Park
@sl
prefLabel
So Yeon Park
@ast
So Yeon Park
@en
So Yeon Park
@es
So Yeon Park
@sl
P106
P31
P496
0000-0002-0299-7268